Opens in a new tab

Dr. Lan Ping

Chinese name: 兰平
Professor, Chief Physician, Doctoral Supervisor, Postdoctoral Co-supervisor . Colorectal Surgery
Dr. Lan Ping is Academic Leader of Colorectal Surgery at the Sixth Affiliated Hospital of Sun Yat-sen University and Director of the Guangdong Digestive Disease Clinical Research Centre. A former Vice President of Sun Yat-sen University, he specialises in minimally invasive surgery for colorectal cancer and inflammatory bowel disease and performs over five hundred operations each year.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+
Years in clinical practice
500+
Colorectal surgeries per year
125
Published papers

  • The Physician

About Dr. Lan Ping

Dr. Lan Ping is Academic Leader of Colorectal Surgery at the Sixth Affiliated Hospital of Sun Yat-sen University and Director of the Guangdong Digestive Disease Clinical Research Centre. A former Vice President of Sun Yat-sen University and President of the Sixth Affiliated Hospital, he has devoted more than thirty years to minimally invasive surgery for colorectal cancer and inflammatory bowel disease, performing over five hundred operations each year. His research spans the gut microbiome, colorectal cancer genetics and inflammatory bowel disease, and has been published in leading journals such as Nature and The Lancet Gastroenterology & Hepatology. He is a recipient of the State Council Special Allowance and the National Famous Doctor award.
1、Academic Leader of Colorectal Surgery at the Sixth Affiliated Hospital of Sun Yat-sen University
2、Former Vice President of Sun Yat-sen University and President of the Sixth Affiliated Hospital
3、Director of the Guangdong Digestive Disease Clinical Research Centre
4、Fellow of the Royal College of Surgeons of England and the American College of Surgeons
5、Recipient of the State Council Special Allowance and the National Famous Doctor Outstanding Contribution award
6、Recipient of the Second Class National Science and Technology Progress Award and a First Class Guangdong Science and Technology Progress Award

Dr. Lan Ping ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Colorectal cancer

He performs minimally invasive and open surgery for colorectal cancer, including laparoscopic radical resection and sphincter-preserving operations for low rectal cancer, so that patients achieve complete tumour removal with faster recovery and preserved bowel function after treatment in routine practice.

Inflammatory bowel disease

He treats Crohn's disease and ulcerative colitis with combined medical and surgical management, performing surgery for complications such as strictures, fistulas and abscesses when needed, so that patients with complex disease regain health and avoid repeated emergency operations and hospital stays.

Recurrent and locally advanced colorectal cancer

He manages locally advanced and recurrent colorectal cancer together with pelvic tumours, combining radical resection with chemotherapy, radiotherapy and immunotherapy in a multidisciplinary team, so that patients with difficult disease receive complete treatment and better long-term survival and quality of life.

More： colorectal cancer screening——early detection; gut microbiome——research; ulcerative colitis——surgical treatment; Crohn’s disease——complication surgery; minimally invasive surgery——laparoscopy

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Gut Fungal Microbiome and Crohn’s Disease (Nature Metabolism)
This study profiled the gut mucosal fungal microbiome in Crohn’s disease and identified an anti-inflammatory effect of the fungus Cladosporium sphaerospermum mediated by antimicrobial peptides, offering new clinical insight for patients with inflammatory bowel disease and supporting potential microbe-based therapies.
2. Neoadjuvant Immunotherapy for Mismatch Repair-Deficient Colorectal Cancer (PICC-2 Trial)
The PICC-2 randomized phase 2 trial compared neoadjuvant toripalimab plus celecoxib with toripalimab alone in patients with mismatch repair-deficient or microsatellite instability-high locally advanced colorectal cancer. It explored whether adding celecoxib improves responses before surgery, informing immunotherapy strategies for this patient group.
3. circRNA Signature Predicts Postoperative Recurrence in Stage II/III Colon Cancer
This translational study developed a circular RNA signature that predicts postoperative recurrence risk in stage II and III colon cancer, helping clinicians decide which patients need closer surveillance or adjuvant treatment after curative colon cancer surgery. It supports precision follow-up for operable colon cancer patients.
4. Tianhe Procedure: Sphincter-Preserving Surgery for Rectal Cancer After Radiotherapy
This standardized surgical protocol describes proximally extended resection combined with sphincter-preserving surgery for rectal cancer after radiotherapy. The Tianhe procedure addresses anastomotic healing and anal preservation in irradiated pelvises, guiding colorectal surgeons who treat locally advanced low rectal cancer with difficult radiotherapy-damaged tissue.
5. Official Specialty Profile of a Colorectal Surgery Leader
This official profile outlines long-standing leadership in colorectal surgery, including multidisciplinary treatment of colon and rectal cancer, inflammatory bowel disease, and complex pelvic tumors. It helps patients find an experienced specialist for difficult colorectal cancer and anal-preserving surgery in Guangzhou.
6. FOWARC Trial: Chemotherapy-Based Neoadjuvant Treatment for Rectal Cancer
As a leading investigator, he contributed to the FOWARC multicenter randomized trial testing modified FOLFOX6 with or without radiation in locally advanced rectal cancer. The results clarified downstaging and organ-preservation outcomes, guiding individualized neoadjuvant decisions for rectal cancer patients in China.
  • Affiliated Hospital

Where Dr. Lan Ping practices

Guangzhou

The Sixth Affiliated Hospital, Sun Yat-sen University

Chinese name: 中山大学附属第六医院
Founded in 1964, Sun Yat-sen University Sixth Affiliated Hospital is a Grade-A tertiary hospital renowned for gastrointestinal surgery and reproductive medicine, holding 3 national key specialties and the world's largest IBD case volume, opening 1,497 beds and ranking A+ nationally.
Since 1964
62 years of care
1,497
Licensed beds
6,415
Colorectal surgeries (2024)
1.66 million
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Lan Ping?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Lan Ping.